Search Results

You searched for : Daiichi  

	Daiichi Sankyo Submits Application for Additional Indication of Mirogabalin in Japan New uses of Mirogabalin claimed by Daiichi... May 17
	Daiichi Sankyo enters into outsourcing agreement to manufacture AstraZeneca COVID-19 Vaccine in Japan Daiichi Sankyo will use undiluted solutions provided by AstraZeneca to manufacture COVID-19 vaccines in Japan... Feb 10
	Enhertu approved in the US for the treatment of patients with previously treated HER2-positive advanced gastric cancer In the US, gastric cancer is most frequently diagnosed in the advanced stage, with only approximately 5% of patients surviving beyond five years.... Jan 18
	Lupin receives approval from US FDA for Colesevelam Hydrochloride tablets Another USFDA approval for Lupin... Dec 18
	Trastuzumab deruxtecan recommended for approval in the EU by CHMP for HER2-positive metastatic breast cancer The impact of the disease is significant, with breast cancer responsible for more than 137,000 deaths per year.... Dec 14
	Enhertu continues to demonstrate durable responses with new data from DESTINY-Breast01 in HER2 Enhertu continued to demonstrate impressive efficacy and durable responses in patients with HER2-positive metastatic breast cancer following two or more prior HER2-based regimens.... Dec 10
	Enhertu granted Priority Review in the US for the treatment of HER2-positive metastatic gastric cancer Only HER2-directed medicine to demonstrate significant improvement in overall survival compared to chemotherapy... Oct 28
	Rain Therapeutics Inc licenses DS3032 from Daiichi Sankyo for treating solid tumors RAIN-32 is a potent and selective MDM2 inhibitor that has been evaluated in clinical trials for solid tumors and hematologic malignancies... Sep 03
	Thermo Fisher and Daiichi Sankyo joins hands : Non small cell cancer Two pharma giants come together for developing Global Companion Diagnostics for patients with NSCLC cancer... Jun 25
	VerifyMe Technologies to Combat World-Wide Counterfeit Drug Epidemic VerifyMe and Techind will work together in providing the VeriPAS(TM) serialization... Jun 16
10 Matching result(s) found!

Trending Now
	Vahan.ai Advances Multilingual AI Recruitment with NVIDIA NemotronAugust 25, 2026
	Vahan.ai Advances Multilingual AI Recruitment with NVIDIA NemotronAugust 25, 2026
	Beyond Basic Baby Care: Addressing the Monsoon Surge in Infant Skin Concerns with Salve’s Littloo RangeAugust 25, 2026
	100+ Bengaluru Clinics Use QR678® as Indian Hair Regeneration Platform Adds New Patent and Expands GloballyAugust 25, 2026
	Healthcare Innovation in India: Real Stories That Are Reshaping the Future of MedicineAugust 25, 2026
	Generative AI in Indian Hospitals: Where It Is Actually Making a Difference in 2026August 25, 2026
	High Uric Acid and Gout: Symptoms, Causes, Diet, Tests, and Treatment ExplainedAugust 24, 2026
	Vitamin D Deficiency in India: Symptoms, Causes, Tests, Treatment and PreventionAugust 24, 2026
	SRM College of Pharmacy Hosts Two-Day National Pharmaceutical ConferenceAugust 21, 2026
	Atomy India Joins Hands with the Paralympic Committee of India as OfficialNutrition and Wellness PartnerAugust 21, 2026
	Thumbay International Pathway - MD Program with Installments and a Direct Route to Residency in RomaniaAugust 21, 2026
	THIP wins ‘Breakthrough Digital Patient Education Initiative’ award at India Vaccine Leaders Conclave in PuneAugust 21, 2026
	Three Watermelons, a Mannequin Head and a PS5: What India Left Behind on Intercity BusesAugust 21, 2026
	Evaluating Thyroid Nodules: Fine Needle Aspiration Cytology (FNAC) and Bethesda ClassificationAugust 21, 2026
	Clinical Approaches to Acute Kidney Injury (AKI): Biomarkers, Staging, and Renal Replacement TherapyAugust 21, 2026
	Diabetes Care in India: Understanding the Crisis, Bridging the Gaps, and Building a Healthier FutureAugust 21, 2026
	Diabetes Management: Lifestyle Changes That Make a Real DifferenceAugust 21, 2026
	TagMango introduces New AI capabilities for creator businesses at RISE 2026August 20, 2026
	AFib: The Irregular Heartbeat We Need to Stop IgnoringAugust 20, 2026
	Nanavati Max Launches Dedicated Cancer Helpline to Support Patients and Families In Their Cancer JourneyAugust 20, 2026